Hepatitis: all 3,372 studies
Page 22 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 YearsTerminatedNCT02166671Not applicable
- An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantCompletedNCT02165189Phase 2
- Pirfenidone, an Antifibrotic and Antiinflammatory DrugCompletedNCT02161952Phase 2
- A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis CNo longer availableNCT02161939
- Metadoxine as a Therapy for Severe Alcoholic HepatitisCompletedNCT02161653Phase 4
- Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002)CompletedNCT02161510Phase 1
- DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)CompletedNCT02156570Phase 4
- Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B VaccineCompletedNCT02152709Phase 3
- A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin.Status unknownNCT02150291Phase 4
- Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker DiversityStatus unknownNCT02148562
- Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
- Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter StudyStatus unknownNCT02143180
- Patient-Centered Care and Asian AmericansCompletedNCT02139722Not applicable
- Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)WithdrawnNCT02135666Phase 4
- PROLIFICA - West African Treatment Cohort for Hepatitis BCompletedNCT02129829
- Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic DiseaseTerminatedNCT02128503Not applicable
- Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) InfectionStatus unknownNCT02126137Phase 1
- Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infectionCompletedNCT02125500Phase 2
- Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver TransplantationCompletedNCT02125071
- Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®WithdrawnNCT02124785Phase 4
- UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT02123654Phase 3
- Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis CCompletedNCT02123212Not applicable
- Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis CTerminatedNCT02120274Phase 4
- TD-6450 MAD Study in HCV Infected SubjectsCompletedNCT02116543Phase 1
- DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice ClientsCompletedNCT02116179Not applicable
- Comparative Effectiveness and Tolerability of Boceprevir vs TelaprevirCompletedNCT02113631Not applicable
- Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected SubjectsTerminatedNCT02112942Phase 1
- Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in MexicoCompletedNCT02112890
- Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B PatientsCompletedNCT02112799Phase 1
- Boceprevir in End Stage Renal Disease (ESRD)WithdrawnNCT02112630Not applicable
- Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma PatientsCompletedNCT02108444
- Hepatitis C in Renal Transplant RecipientsStatus unknownNCT02108301Phase 4
- A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With SimeprevirCompletedNCT02103699
- Control and Elimination Within Australia of Hepatitis C From People Living With HIVStatus unknownNCT02102451
- Evaluation of the National Treatment Program of Hepatitis C in EgyptWithdrawnNCT02101177
- Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis CWithdrawnNCT02099604Phase 3
- Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C VirusCompletedNCT02098616Not applicable
- EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis CNo longer availableNCT02097966
- Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B InfectionCompletedNCT02097004Phase 4
- DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompletedNCT02094833Phase 3
- Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to CareTerminatedNCT02084719Not applicable
- Prophylaxis of CHB Patients With Malignant Tumor Receiving ChemotherapyCompletedNCT02081469Phase 4
- NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced HepatitisStatus unknownNCT02076685Not applicable
- Integrated Approaches for Identifying Molecular Targets in Alcoholic HepatitisCompletedNCT02075918
- Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis BCompletedNCT02075294
- TO Compare the Triple Drug Therapy and Dual Therapy .Status unknownNCT02075242Phase 4
- Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C InfectionWithdrawnNCT02070107Not applicable
- Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis BCompletedNCT02069678
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for TestingCompletedNCT02068963
- Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C PatientsCompletedNCT02065999
- Surveillance and Treatment of Prisoners With Hepatitis CCompletedNCT02064049Phase 4
- The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C PatientsCompletedNCT02063607Phase 1
- Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern AfricaCompletedNCT02060162
- Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)Status unknownNCT02057887Phase 1/2
- The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy AdultsCompletedNCT02057263Phase 1
- Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected PatientsStatus unknownNCT02057003
- Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic MalignancyStatus unknownNCT02056548
- De Novo Autoimmune Hepatitis in Pediatric Liver TransplantationTerminatedNCT02056054
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir BackgroundWithdrawnNCT02053727Not applicable
- Can Vitamin D Supplementation Improve Hepatitis C Cure RatesCompletedNCT02053519Phase 3
- The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune HepatitisCompletedNCT02050646Not applicable
- Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal DiseasesWithdrawnNCT02049736Not applicable
- Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundCompletedNCT02044523
- Mother-to-child Hepatitis D TransmissionCompletedNCT02044055
- Vertical Transmission of Hepatitis C VirusStatus unknownNCT02044042
- Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisCompletedNCT02040636Phase 2
- Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT02038387Not applicable
- A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B VaccinesCompletedNCT02032160Not applicable
- Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLDCompletedNCT02031913
- Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCVCompletedNCT02027493Not applicable
- Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C InfectionCompletedNCT02027116Phase 1
- Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular CarcinomaCompletedNCT02025842
- Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With CholestasisStatus unknownNCT02024295Phase 4
- TD-6450 SAD and MAD in Healthy SubjectsCompletedNCT02022306Phase 1
- Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic HepatitisCompletedNCT02019056Phase 2
- To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI BleedCompletedNCT02015403Not applicable
- Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.CompletedNCT02014571Phase 1
- Prospective Observational Study of Disease Progression in Chronic Hepatitis CActive, not recruitingNCT02011932
- Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and AdolescentsCompletedNCT02011763Phase 4
- Patient Self-management and Gene Guided Therapy for Chronic Hepatitis CCompletedNCT02006823
- Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide AnalogsCompletedNCT02005146
- Register of Telaprevir and Boceprevir in Routine Clinical PracticeCompletedNCT02004379
- Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .CompletedNCT02003703Phase 3
- The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy ChildrenCompletedNCT02002065
- Australian Trial in Acute Hepatitis C Recall StudyCompletedNCT02000063
- A Study of the Immune Response to Heplisav in Healthy Older AdultsCompletedNCT01999699Phase 1
- Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With CholestasisStatus unknownNCT01998620Phase 4
- Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B PatientsCompletedNCT01997944Phase 1/2
- Long Term Vitamin D Therapy in HCV Treated PatientsTerminatedNCT01997203Phase 3
- Non-invasive Biomarkers of Fibrosis in Pediatric Liver DiseasesCompletedNCT01988753
- Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B CirrhosisStatus unknownNCT01987791
- Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
- CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITISCompletedNCT01980745Phase 4
- Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis CCompletedNCT01980290
- UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic SubjectsCompletedNCT01979939Phase 3
- Hepatitis B Seroepidemiology Among Young AdultsStatus unknownNCT01973582
- UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated CirrhosisCompletedNCT01973049Phase 3
- Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve PatientsCompletedNCT01970904Not applicable
- Widespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyCompletedNCT01970254
- A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical TrialStatus unknownNCT01965418Phase 4